You are looking for

Does Europe have a proper start-up culture? Are we doing enough for young professionals? According to Neelie Kroes, Vice-President of the European Commission, in her article for the World Economic Forum, we could do more to make Europe fertile ground for start-ups, and engage the youngest generation entering the workforce. As a young professional in Brussels well-acquainted with millennial woes, I was eminently interested in the views of an established and influential official at the European Union.

Why do the mHealth Grand Tour, I mean, I’ve never been a sporting cyclist (yes, I’ve commuted by bike for years but not a 100 miles a day) nor am I a huge Tour de France fan, neither do I have diabetes… and developing a rather numb posterior, day after day, seriously?

With its Contract for a Healthy Future,  the medical technology industry acknowledges its role and responsibility in maintaining high-quality, affordable healthcare in Europe despite an ageing population and constrained budgets. This industry commitment offers the much needed solutions to prove that innovation is not a cost driver but a facilitator for driving healthcare quality and efficiency in the future.  From personalized medicine to disease monitoring, the role of the diagnostics industry will be crucial in managing healthcare spending.

I was diagnosed with Diabetes Type I in December 1997 at the age of 19. I had just graduated from high school, moved to the city, started university and was in the middle of applying for Harvard and MIT scholarships. I thought personal computers and Microsoft Windows 95 uncool, had gone through my range of Ataris and C64s, and was proud owner of my first Apple Macintosh Performa – 56k modem and all. And my first, brick-like cellphone was soon to be exchanged for Nokia’s 7622, one of the first mobile phones with WAP technology: Internet on the go.

In vitro diagnostic (IVD) tests are likely to be a part of everyone’s life, in many cases, more than once. Yet most people do not know what these tests are or what they do.

For the past two years, I have been working with great passion on the subject of mobile health (or mHealth), having set up the global mHealth programme of the GSMA – the organisation that represents the interests of mobile operators worldwide. I am therefore very pleased that the momentum for mHealth has really been building.

When UBM Canon decided to launch the MEDTEC EMDT Innovation Awards, the PIP implant affair was not front-page news. The organisers merely thought that the contributions made by Europe’s medical technology industry in ameliorating the human condition deserved recognition. But in the aftermath of the wall-to-wall coverage of the French breast implant scandal, it’s more important than ever to celebrate and trumpet the achievements of this remarkable industry.

As one of the baby boomers and firmly fingered with responsibility for both the healthcare funding and pensions crises, it is with a very personal interest that I look at emerging trends in care of the chronically sick and ageing. Age unfortunately means collecting co-morbidities, hopefully minor ones, and dealing with them in a way […]

The prominence of World Kidney Day (11th March) brings into sharp focus the changing epidemiology of our times and the impact of modern life styles of the developed world on the demands placed on healthcare systems. The surge in incidence of diabetes coupled with extending life expectancy are producing a parallel rise in the incidence […]